secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001193125-25-061426
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose converts $1.5M debt into 409,063 shares at $3.70; amends investor rights with Hanmi
--------------------------------------------------------------------------------

- Converted $1,513,533.10 of debt owed to Hanmi into 409,063 common shares at $3.70 per share.
- Interest for Dec. 21, 2024–Mar. 31, 2025 deferred; must be paid by June 27, 2025 to avoid default.
- Amended investor rights: Hanmi gets demand and piggyback registration rights; can nominate employees if ownership ≥10%.
- Company plans $15M capital raise; additional debt conversions allowed post-raise at Hanmi's discretion subject to 19.99% cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525061426/0001193125-25-061426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525061426/d943621d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-061426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer